Oxford Science Enterprises | Activity | F4Oxford Science Enterprises Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Team Change
OSE appointed Antonia Jenkinson as Chief Financial Officer.
Antonia Jenkinson appointed Chief Financial Officer
Oxford spinout Stateful Robotics raised $4.8m pre-seed to bring long-horizon intelligence to real-world robotics.
Investment
Densix raised a $4m seed round to redefine power density for AI data centres and power grids.
Densix
Team Change
OSE announced new board appointments.
OSE announces new board appointments
Exit
Portfolio company Dark Blue Therapeutics was acquired in a deal worth up to $840m.
Dark Blue Therapeutics
Essay
Partner Joel Schoppig published a thesis essay on why OSE invested in Kneu Health.
Why we invested in Kneu Health
Investment
OSE and Ellison Institute of Technology made their first co-investment in a $60m Series A for Wild Bioscience to boost global agricultural resilience.
Wild Bioscience
Essay
Sam Harman, Head of Deep Tech, wrote on how regional clusters can power the UK's quantum revolution.
How regional clusters can power the UK's quantum revolution
Exit
Oxford Ionics reached agreement to be acquired by IonQ for $1.075 billion, OSE's largest exit and the UK's first $1bn+ deep-science spinout.
Oxford Ionics
Podcast
CEO Ed Bussey discussed solving the greatest problem holding back UK tech on the UKTN Podcast.
Ed Bussey on the UKTN Podcast
News
Oxford Science Enterprises raised $232m in debt financing from banks.
OSE raises $232m from banks
News
Aviva injected £15m into Oxford Science Enterprises to support Oxford spinouts.
Aviva injects £15m into Oxford Science Enterprises
Press
CEO Ed Bussey discussed OSE's mission to build world-changing companies with The Times.
Lunch With The Times: Ed Bussey
Exit
Portfolio company Oxford Semantic Technologies was acquired by Samsung Electronics.
Oxford Semantic Technologies